CEP170 and non-small cell lung carcinoma: Indeed, TBK1 could interact with CEP170 and NuMA in H1650 NSCLC cells (Fig. 5b) and this interaction was augmented during mitosis and abolished by treatment with BX795 (Fig. 5c).